Sort
82,697 grants matching “vaccine development”
Immune Responses to Vibrio cholerae infection and vaccination in Haiti
$773,078Jason B Harris · Massachusetts General Hospital · R01 · FY2012 · AI
Impact of chronic viral infections and altered microbiota on HIV vaccine efficacy
$773,051Satya Dandekar · University Of California At Davis · R56 · FY2015 · AI
Characteristics and protective efficacy of human antibodies against M. tuberculosis
$773,048Jacqueline Michele Achkar · Albert Einstein College Of Medicine · R01 · FY2021 · AI
Recombinant Vaccines for Prevention of AIDS and Other Diseases
$772,994Bernard Moss · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Persistent H. influenzae in COPD - virulence, vaccines and antibiotic resistance
$772,946Timothy F Murphy · State University Of New York At Buffalo · R01 · FY2015 · AI
Molecular biology of human polyomaviruses
$772,907Christopher Buck · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
BKV and JCV vaccine development
$772,907Christopher Buck · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Developing broad-spectrum therapeutics against C. difficile toxins
$772,904Rongsheng Jin · University Of California-Irvine · R01 · FY2023 · AI
The yellow fever vaccine saga: Defining the viral and host determinants responsible for success versus failure
$772,861Charles M. Rice · Rockefeller University · R01 · FY2018 · AI
Collision of Alzheimers disease and COVID-19 pandemic in the United States: risks, outcomes, disparities and treatments
$772,838Rong Xu · Case Western Reserve University · R01 · FY2025 · AG
Vaccine Studies of Simian Immunodeficiency Virus (SIV) in Macaques
$772,823Vanessa M. Hirsch · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Preventing TB with intravenous BCG in SIV-infected macaques
$772,812Charles A. Scanga · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AI
Deep Learning-based Protein Design of HIV-1 Env GP120 Core Immunogens for CD4 Binding Site Germline Targeting
$772,776Marie Pancera · Fred Hutchinson Cancer Center · R01 · FY2025 · AI
Role of Follicular T Helper Cells In Enhancing Humoral Immunity and Protection
$772,706Rafi Ahmed · Emory University · U19 · FY2015 · AI
Revolutionary Eilat-based Chikungunya Vaccine Vector
$772,684Tian Wang · University Of Texas Med Br Galveston · R01 · FY2019 · AI
Role of B Lymphocytes In HIV Infection And Pathogenesis
$772,682Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Evolutionary lead optimization for immunotherapy of Marburg & Ebola viruses
$772,657Adam Lacy-Hulbert · Massachusetts General Hospital · U01 · FY2010 · AI
Therapeutic Vaccine Targeting CMV Antigens in Glioblastoma
$772,615John H Sampson · Annias Immunotherapeutics, Inc. · R42 · FY2017 · CA
Synthesis of Antitumor Natural Products
$772,528Samuel J Danishefsky · Sloan-Kettering Inst Can Research · R37 · FY2009 · CA
Migratory Properties of HIV-infected T cells in vivo
$772,503Thorsten Roman Mempel · Massachusetts General Hospital · R01 · FY2014 · AI
A prophylactic vaccine to prevent colonization by Pseudomonas aeruginosa
$772,498Wendy L Picking · University Of Missouri-Columbia · R01 · FY2024 · AI
A prophylactic vaccine to prevent colonization by Pseudomonas aeruginosa
$772,498Wendy L Picking · University Of Missouri-Columbia · R01 · FY2025 · AI
Antiviral agents directed to novel targets in the adenovirus proteinase
$772,490Walter F. Mangel · Brookhaven Science Assoc-Brookhaven Lab · R01 · FY2009 · AI
Intestinal microbiota-mediated rotavirus vaccine failure
$772,481Andrew T Gewirtz · Georgia State University · R01 · FY2022 · AI
Systems Biology of Mumps Vaccine Response
$772,439Richard B Kennedy · Mayo Clinic Rochester · R01 · FY2022 · AI